ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,070.80
      -0.05%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.67%
      Bitcoin
      66,809.51
      2.41%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSXV
      6. RepliCel Life Sciences Inc (RP)

      7. RepliCel Life Sciences Inc (RP) News

      RP

      RepliCel Life Sciences (RP)

      RepliCel Life Sciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:TSXV:RP
      DateTimeSourceHeadlineSymbolCompany
      3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
      05/08/20248:14AMPR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - RPTSXV:RPRepliCel Life Sciences Inc
      05/08/20248:11AMPR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - RPTSXV:RPRepliCel Life Sciences Inc
      11/28/202311:48PMPR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:RPRepliCel Life Sciences Inc
      01/04/20239:04PMPR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:RPRepliCel Life Sciences Inc
      12/23/20196:00AMPR Newswire (Canada)RepliCel Announces its Incoming Board of DirectorsTSXV:RPRepliCel Life Sciences Inc
      11/26/20196:00AMPR Newswire (Canada)RepliCel Provides 2019 Year-End UpdateTSXV:RPRepliCel Life Sciences Inc
      09/24/20196:00AMPR Newswire (Canada)Clinical Data Published from RepliCel's Skin Rejuvenation StudyTSXV:RPRepliCel Life Sciences Inc
      09/10/20196:00AMPR Newswire (Canada)RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in ChinaTSXV:RPRepliCel Life Sciences Inc
      08/29/20196:00AMPR Newswire (Canada)RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Auto...TSXV:RPRepliCel Life Sciences Inc
      04/16/20196:00AMPR Newswire (Canada)RepliCel Secures Several New Patents for its Regenerative Medicine TechnologiesTSXV:RPRepliCel Life Sciences Inc
      03/26/20196:00AMPR Newswire (Canada)RepliCel's Licensee Building Momentum in China with Facility and TeamTSXV:RPRepliCel Life Sciences Inc
      03/19/20196:00AMPR Newswire (Canada)RepliCel Reignites its First-in-Japan StrategyTSXV:RPRepliCel Life Sciences Inc
      03/05/20196:00AMPR Newswire (Canada)RepliCel CEO Provides 2019 Shareholder UpdateTSXV:RPRepliCel Life Sciences Inc
      11/06/20186:00AMPR Newswire (Canada)RepliCel Life Sciences Appoints Head of Clinical and Regulatory AffairsTSXV:RPRepliCel Life Sciences Inc
      10/18/20186:00AMPR Newswire (Canada)RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, CanadaTSXV:RPRepliCel Life Sciences Inc
      10/17/20186:00AMPR Newswire (Canada)RepliCel Life Sciences Appoints New Chief Financial OfficerTSXV:RPRepliCel Life Sciences Inc
      10/15/20186:00AMPR Newswire (Canada)RepliCel CEO Provides Updated OutlookTSXV:RPRepliCel Life Sciences Inc
      10/11/20186:00AMPR Newswire (Canada)RepliCel Life Sciences Completes Financing with YOFOTO (China) HealthTSXV:RPRepliCel Life Sciences Inc
      09/24/20186:00AMPR Newswire (Canada)RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete InvestmentTSXV:RPRepliCel Life Sciences Inc
      07/11/20186:00AMPR Newswire (Canada)RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater ChinaTSXV:RPRepliCel Life Sciences Inc
      05/02/20186:00AMPR Newswire (Canada)RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTOTSXV:RPRepliCel Life Sciences Inc
      01/25/20186:00AMPR Newswire (Canada)RepliCel CEO Provides 2018 Shareholder UpdateTSXV:RPRepliCel Life Sciences Inc
      01/16/20186:00AMPR Newswire (Canada)RepliCel Life Sciences Lands Commitment for Key Investment PartnershipTSXV:RPRepliCel Life Sciences Inc
      10/19/20175:00PMPR Newswire (Canada)RepliCel Life Sciences Successfully Closes FinancingTSXV:RPRepliCel Life Sciences Inc
      09/22/20178:24PMPR Newswire (Canada)RepliCel Retains Hybrid Financial for Investor RelationsTSXV:RPRepliCel Life Sciences Inc
      09/13/20176:00AMPR Newswire (Canada)RepliCel's Partnership Initiatives Mature into Licensing NegotiationsTSXV:RPRepliCel Life Sciences Inc
      09/07/20176:00AMPR Newswire (Canada)RepliCel Showcases First Fully-Functional Prototypes of its Next-Generation Dermal InjectorTSXV:RPRepliCel Life Sciences Inc
      08/10/20176:00AMPR Newswire (Canada)Prominent Skin Aging Researcher Provides Insights into RepliCel's Clinical DataTSXV:RPRepliCel Life Sciences Inc
      06/13/20176:00AMPR Newswire (Canada)RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data MapTSXV:RPRepliCel Life Sciences Inc
       Showing the most relevant articles for your search:TSXV:RP